Epithalon is a synthetic four-amino-acid peptide derived from epithalamin, a pineal-gland extract studied by a Russian research group since the 1980s. In cell-culture and animal studies it's reported to activate telomerase and lengthen telomeres, and to modulate immune function tied to aging.

Does Epithalon extend lifespan?

The lifespan evidence is a Russian mouse study from 2001. The telomerase work that gets cited most often was done in cultured human cells, not living people, and shows the mechanism working, not a longer life. No human lifespan trial of Epithalon has been published, so the mouse-to-human leap isn't supported yet.

Is Epithalon approved by the FDA?

No. Epithalon has never been FDA-approved. On July 24, 2026, the FDA's Pharmacy Compounding Advisory Committee (PCAC) recommended inclusion of Epithalon on the 503A Bulk Drug Substances List, the list that covers pharmacy compounding. The use put to the committee was insomnia, not anti-aging. That's an advisory vote, not an approval, and FDA final action is pending.

Is Epithalon banned for athletes?

Epithalon isn't named on WADA's list, but as a non-approved peptide with reported activity in animal models, it falls under WADA's category for non-approved substances and should be treated as prohibited. The absence of a name on a list is not the same as a green light for anyone tested under WADA rules.

Epithalon — independent peptide journalism

How it works

A synthetic tetrapeptide based on epithalamin, a pineal gland extract researched by the St. Petersburg Institute of Bioregulation since the 1980s. The anti-aging angle: it reportedly activates telomerase and extends telomere length in cell culture. Rodent lifespan studies from that same research group show extended mean lifespan. The telomerase story is interesting. It's also mostly from one lab, in animals, using in vitro measures. Human evidence doesn't yet exist in a rigorous form.

FDA status: No FDA approval. On July 24, 2026, PCAC recommended inclusion of Epithalon on the 503A Bulk Drug Substances List. FDA final action is pending.
WADA status: Permitted in sport
Route: subcutaneous or intramuscular injection; intranasal

Key studies

Epithalone activates telomerase and elongates telomeres — Khavinson et al. (2003)

Epithalon (Ala-Glu-Asp-Gly) activated telomerase in fetal human fibroblasts and somatic cells, with increased telomere elongation observed in treated cell cultures compared with controls.

Frequently asked

What is Epithalon?
Epithalon is a synthetic four-amino-acid peptide derived from epithalamin, a pineal-gland extract studied by a Russian research group since the 1980s. In cell-culture and animal studies it's reported to activate telomerase and lengthen telomeres, and to modulate immune function tied to aging.
Does Epithalon extend lifespan?
The lifespan evidence is a Russian mouse study from 2001. The telomerase work that gets cited most often was done in cultured human cells, not living people, and shows the mechanism working, not a longer life. No human lifespan trial of Epithalon has been published, so the mouse-to-human leap isn't supported yet.
Is Epithalon approved by the FDA?
No. Epithalon has never been FDA-approved. On July 24, 2026, the FDA's Pharmacy Compounding Advisory Committee (PCAC) recommended inclusion of Epithalon on the 503A Bulk Drug Substances List, the list that covers pharmacy compounding. The use put to the committee was insomnia, not anti-aging. That's an advisory vote, not an approval, and FDA final action is pending.
Is Epithalon banned for athletes?
Epithalon isn't named on WADA's list, but as a non-approved peptide with reported activity in animal models, it falls under WADA's category for non-approved substances and should be treated as prohibited. The absence of a name on a list is not the same as a green light for anyone tested under WADA rules.

Wolverine Health is building physician-supervised peptide protocols. Get early access.

Join the waitlist

Research on Epithalon

What is PCAC? The FDA committee that reviews peptides for compounding

PCAC is the FDA advisory committee that reviews which raw ingredients compounding pharmacies may use. Here is what it does and what its votes mean.

What RFK Jr.'s February 2026 announcement actually said about peptides

The "announcement" was a Joe Rogan appearance, not a Federal Register notice. The wellness scene heard one thing. The actual signal was narrower, and the rulemaking that turns it into access is still more than a year away.

The PCAC review happened July 23–24, 2026. Here is what that means for peptide access.

Two days at FDA's White Oak campus decided which of seven peptides US compounding pharmacies may eventually dispense by prescription. The recommendation is not an approval, the docket is not all the peptides, and the framing the forums used going in was mostly wrong.

Telomeres, explained: the countdown inside your cells — and why longevity science keeps circling it

WADA

Telomeres cap your chromosomes, and get shorter every time a cell divides. Reset that countdown and you'd slow ageing itself — the longevity holy grail. Here's the real biology, what could move it, and why telomere-lengthening as anti-ageing is still unproven in humans.

MOTS-c vs Epitalon: two different bets on ageing slower

WADA

MOTS-c and Epitalon are two very different longevity bets — one on your metabolism, one on the clock inside your cells. Here is what each could do for you, which angle fits your goal, and how far the human proof goes on both.

Epithalon: the four-amino-acid peptide betting it can slow your clock

WADA

Epithalon is the shortest peptide on the longevity menu, built on one bold idea — switching telomerase back on to rebuild the caps on your chromosomes. Here is what it could do for you, how far the proof actually goes, and where it sits on the July 2026 PCAC docket.

How it works

Key studies

Frequently asked

What is Epithalon?

Does Epithalon extend lifespan?

Is Epithalon approved by the FDA?

Is Epithalon banned for athletes?

Research on Epithalon